Literature DB >> 8222563

Lung cancer in the elderly patient.

T L Lee-Chiong1, R A Matthay.   

Abstract

One half of all cases of lung cancer occur in patients aged 65 years and older. Although adenocarcinoma is the predominant histologic subtype in the general population, squamous cell carcinoma has remained the most common type in the elderly. Although lung cancer tends to present at a less advanced stage with increasing age, the percentage of elderly patients undergoing treatment tends to decline despite the fact that they can tolerate the aggressive therapy that may enhance survival.

Entities:  

Mesh:

Year:  1993        PMID: 8222563

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  6 in total

1.  Age and the treatment of lung cancer.

Authors:  J S Brown; D Eraut; C Trask; A G Davison
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

2.  Outcome of surgery for lung cancer in young and elderly patients.

Authors:  Serkan Yazgan; Soner Gürsoy; Sadik Yaldiz; Oktay Basok
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group study.

Authors:  Kazunari Tateishi; Takashi Ichiyama; Kazuya Hirai; Toshihiko Agatsuma; Shigeru Koyama; Tsutomu Hachiya; Nobutoshi Morozumi; Takayuki Shiina; Tomonobu Koizumi
Journal:  Med Oncol       Date:  2013-01-13       Impact factor: 3.064

4.  Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer.

Authors:  Sonya Haslam; Paul Chrisp
Journal:  Core Evid       Date:  2007-03-31

5.  Computed Tomography-Guided Percutaneous Radiofrequency Ablation in Older Adults With Early-Stage Peripheral Lung Cancer: A Retrospective Cohort Study.

Authors:  Yanda Lu; Caiwei Lu; Danni Xu; Fen Huang; Zhihui He; Junhua Lei; Huamao Sun; Jiangzheng Zeng
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

6.  Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan.

Authors:  Hsiu-Ling Huang; Pei-Tseng Kung; Chang-Fang Chiu; Yueh-Hsin Wang; Wen-Chen Tsai
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.